Articles

OVID – PHASE 1 TRIAL GOOD ENOUGH, CAPITAL RAISE DOES RAISE SOME QUESTIONS

08 October 2025

OVID – PHASE 1 TRIAL GOOD ENOUGH, CAPITAL RAISE DOES RAISE SOME QUESTIONS

Ovid Therapeutics (OVID – NASDAQ) came out with their Phase 1 study results in OV329 targeting...

Read more
THE REAL SPARE CAPACITY

03 October 2025

THE REAL SPARE CAPACITY

The talk of the town in the oil market is spare capacity. OPEC+ spare capacity. When...

Read more
Canary Gold–BRAZ-CSE / CNYGF-OTC

02 October 2025

Canary Gold–BRAZ-CSE / CNYGF-OTC

The Massive, Simple, Scalable Gold Play You’ve Never Heard Of—Yet Unique ideas are rare in mining/mineral...

Read more
THIS VACCINE ALTERNATIVE COULD BE A BIG WINNER INVIVYD (IVVD – NASD)

25 September 2025

THIS VACCINE ALTERNATIVE COULD BE A BIG WINNER INVIVYD (IVVD – NASD)

In the US in 2024, Covid vaccine uptake was 23% among adults and 14% among children....

Read more
BYRNA TECHNOLOGIES (BYRN – NASDAQ) CAN WE HIT the BULLSEYE TWICE?

12 September 2025

BYRNA TECHNOLOGIES (BYRN – NASDAQ) CAN WE HIT the BULLSEYE TWICE?

Byrna Technologies (BYRN – NASDAQ) is a good lesson in why it’s not a good idea...

Read more

Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.